Gleevec® (Imatinib Mesylate)

Gleevec® (Imatinib Mesylate)

GLEEVEC® (imatinib mesylate) tablets have delivered efficacy and safety data backed by almost two decades of clinical use. First approved by the FDA in 2011, the figures speak for themselves. Learn more below.